Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
John C. Moran Insider Profile
4 Followers
John C. Moran, Director at Anika Therapeutics, holds 14.80K shares in Anika Therapeutics (Ticker: ANIK). Most recently, John C. Moran Sold $2,000 shares of Anika Therapeutics on Aug 11, 2015 for an estimated value of 72.36K.
Profitable Transactions
1 out of 5 Profitable Transactions
Average Return
-25.90%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that John C. Moran holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Sell
Date:Jun 03, 2014 - Jun 03, 2015
Return:+28.80%
The most profitable trade made by John C. Moran
John C. Moran's Trading History
List of latest transactions for each holding click on a transaction to see John C. Moran's performance on stock
You May Also Like
John C. Moran insider profile FAQ
What is the percentage of profitable transactions made by John C. Moran?
The percentage of profitable transactions made by John C. Moran is 20%.
What is the average return per transaction made by John C. Moran?
The average return per transaction made by John C. Moran is -25.90%.
What stocks does John C. Moran hold?
John C. Moran holds: ANIK stocks.
What was John C. Moran’s latest transaction?
John C. Moran latest transaction was an Informative Sell of $72.36K.
What was John C. Moran's most profitable transaction?
John C. Moran’s most profitable transaction was an Informative Sell of ANIK stock on June 3, 2014. The return on the trade was 28.80%.
What is John C. Moran's role in Anika Therapeutics?
John C. Moran's role in Anika Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.